Compare Hershey Co (HSY) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hershey Co vs Oscar Health Inc — how do they compare? Hershey Co trades at $171.69 (market cap $34.83B), while Oscar Health Inc trades at $29.22 (market cap $9.28B). The key difference: Hershey Co is far larger — about 3.8× Oscar Health Inc's market cap, and Hershey Co pays a 3.38% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals.
| HSY | OSCR | |
|---|---|---|
Market Cap | $34.83B | $9.28B |
Sector | Consumer Staples | Health |
52-Week High | $236.28 | $32.18 |
52-Week Low | $162.31 | $10.85 |
Enterprise Value | $39.63B | $4.90B |
Dividend Yield | 3.38% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hershey (HSY) trades at $170.63, down 0.46% on the day, with a bearish technical signal from moving averages. The company reported revenue of $11.69B for 2025 with a net income margin of 9.12%, though margins have compressed from prior years. Recent earnings have consistently beaten expectations, and the company announced a $1.45 dividend payable in June 2026. Analyst consensus is a 'Hold' with a price target of $207.82, indicating potential upside from current levels.
The outlook for HSY hinges on margin recovery as high cocoa costs cycle out. While valuation multiples appear elevated, consistent earnings beats and a solid dividend yield of approximately 3.4% provide support. Key risks include persistent volume weakness and competitive pressures. The stock presents a cautious opportunity for investors betting on a fundamental rebound in the second half of 2026.
Oscar Health (OSCR) trades at $29.60, up 1.72% with mixed technical signals showing neutral overall momentum. The company reported strong Q1 2026 earnings beat but faces profitability challenges with negative margins. Revenue growth from $11.7B in 2025 to projected $13.3B in 2026 indicates expansion, while cash flow trends show operational improvement. Analyst consensus is divided with 27% buy ratings against a $24.67 price target below current levels.
The stock presents growth potential through revenue expansion and cash flow generation, but profitability concerns and negative ROE pose significant risks. Current valuation at 0.61 P/S suggests reasonable pricing for growth, though execution on margin improvement remains critical for sustained upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hershey Co
Hershey is a leading confectionery manufacturer in the U.S. (around a $25 billion market), controlling around 46% of the domestic chocolate space (per IRI). Beyond its namesake label, the firm's mix has expanded over the last 85 years and now consists of 100 brands, including Reese's, Kit Kat, Kisses, and Ice Breakers. Hershey's products are sold in about 80 countries, albeit with just a high-single-digit percentage of sales coming from markets outside the U.S., including Brazil, India, and Mexico. The firm has sought inorganic opportunities to extend its reach beyond its core confection business, adding Amplify Snack Brands and its Skinny Pop ready-to-eat popcorn to its mix and Pirate Brands (including the Pirate's Booty, Smart Puffs, and Original Tings brands) over the past few years.
Read more on HSY →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
